Cargando…
Effectiveness and safety of tocilizumab for COVID-19: a systematic review and meta-analysis of randomized clinical trials
BACKGROUND: Tocilizumab is an anti-human interleukin 6 receptor monoclonal antibody that has been used to treat coronavirus disease 2019 (COVID-19). However, there is no consensus on its efficacy for the treatment of COVID-19. OBJECTIVE: To evaluate the effectiveness and safety of tocilizumab for tr...
Autores principales: | Almeida, Paula Ribeiro Lopes, Person, Osmar Clayton, Puga, Maria Eduarda dos Santos, Giusti, Maria Fernanda, Pinto, Ana Carolina Pereira Nunes, Rocha, Aline Pereira, Atallah, Álvaro Nagib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Paulista de Medicina - APM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005468/ https://www.ncbi.nlm.nih.gov/pubmed/36102463 http://dx.doi.org/10.1590/1516-3180.2022.0170.R1.01072022 |
Ejemplares similares
-
Cochrane Library: the best evidence within everyone's reach
por: Puga, Maria Eduarda dos Santos, et al.
Publicado: (2020) -
Web of Science Journal Citation Report 2020: the Brazilian contribution to the “Medicine, General & Internal” category of the journal impact factor (JIF) ranking (SCI 2019)
por: Atallah, Álvaro Nagib, et al.
Publicado: (2020) -
COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review
por: da Rocha, Aline Pereira, et al.
Publicado: (2020) -
SARS-CoV-2 and arbovirus infection: a rapid systematic review
por: Milby, Keilla Martins, et al.
Publicado: (2020) -
What do Cochrane systematic reviews say about telemedicine for healthcare?
por: Flumignan, Carolina Dutra Queiroz, et al.
Publicado: (2019)